The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1107
ISSUE1107
June 25, 2001
A New Snake Antivenom
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
A New Snake Antivenom
June 25, 2001 (Issue: 1107)
CroFab, an antigen-binding-fragment (Fab) antivenom of ovine origin, has been approved by the FDA for treatment of North American rattlesnake envenomation.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.